Streetbeat News

AHI

Advanced Human Imaging Limited

https://www.advancedhumanimaging.com

Industry

Software - Application

Advanced Human Imaging Limited operates as a mobile application and technology development company worldwide. It develops and patents a proprietary measurement/dimensioning technology that enables end-user to check, track, and assess body dimensions privately using a smartphone. The company offers smartphone-based human scanning technology, such as BodyScan, FaceScan, DermaScan, MKScan, and HemaScan. It serves mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. The company was formerly known as MyFiziq Limited and changed its name to Advanced Human Imaging Limited in March 2021. Advanced Human Imaging Limited was incorporated in 2014 and is based in South Perth, Australia.

Open

N/A

Mkt cap

12M

Volume

N/A

High

1.50

P/E Ratio

-4.69

52-wk high

2.56

Low

1.50

Div yield

N/A

52-wk low

1.41

Armata Pharmaceuticals, Inc. (AHI) received a delisting notification from Nasdaq due to an equity deficiency. The company plans to appeal the decision and address the $1.15 million shortfall with a $1.96 million placement from Oakley Capital and a US shelf offering.

Portfolio Pulse from Charles Gross

May 10, 2024 | 10:11 am

Advanced Health Intelligence Ltd (AHI) has extended its Master Services Agreement with UAE-based Pharmak Direct, providing additional time for solution integration. The terms remain unchanged, aiming for completion within the 90-day extension.

Portfolio Pulse from Charles Gross

April 14, 2024 | 11:01 pm

Advanced Health Intelligence (AHI) has requested an extension to its voluntary suspension of securities pending an announcement regarding potential funding solutions.

Portfolio Pulse from Charles Gross

February 15, 2024 | 10:31 am

Trading for AHI was halted at 7:00:00 a.m. ET due to pending news. The halt is a temporary measure until the news affecting the company is released.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 12:00 pm

Motus GI Holdings, Inc. (MOTS) shares plummeted by 46.5% in pre-market trading after announcing a $5 million public offering. Other stocks experienced significant movement in pre-market trading, with notable gainers including Infobird Co., Ltd. (IFBD), Jin Medical International Ltd. (ZJYL), and SOBR Safe, Inc. (SOBR), among others. Conversely, several companies saw their shares decline, such as ETAO International Co., Ltd. (ETAO), bluebird bio, Inc. (BLUE), and Ebix, Inc. (EBIX), which filed for Chapter 11 bankruptcy.

Portfolio Pulse from Avi Kapoor

December 19, 2023 | 1:09 pm

Advanced Health Intelligence Ltd (NASDAQ:AHI) announced it will launch a mobile phone-based Atrial Fibrillation (AF) assessment service in Q2 2024. The service is part of an expansion of the company's Biometric Health Assessment suite, following a binding agreement with Qompium NV. The AF-Scan application is medically approved in multiple regions, including the USA, and aims to address the global prevalence of AF, which affects approximately 60 million people and significantly increases the risk of stroke.

Portfolio Pulse from Charles Gross

November 30, 2023 | 10:17 am

Advanced Health Intelligence Ltd (NASDAQ:AHI) received a deficiency notification from Nasdaq for not complying with the minimum net shareholders' equity requirement of $2.5M. This does not currently affect the company's securities' listing or trading on Nasdaq.

Portfolio Pulse from Charles Gross

November 08, 2023 | 10:12 am

In Tuesday's pre-market session, several health care stocks saw significant movement. Senti Biosciences, Tharimmune, TransMedics Gr, Synlogic, Advanced Health, and Augmedix saw increases, with Senti Biosciences leading with a 139.8% increase. On the other hand, Ventyx Biosciences, Aura Biosciences, Coherus BioSciences, MSP Recovery, Clover Health Investments, and Trevena saw decreases, with Ventyx Biosciences falling the most by 76.2%.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 1:06 pm

Advanced Health Intelligence (AHI) has announced a proposed placement of approximately 10.75 million shares at $0.11 per share.

Portfolio Pulse from Charles Gross

November 05, 2023 | 11:20 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.